Dr Sravan Kumar Appani

Dr Sravan Kumar Appani

Consultant Rheumatologist
  • MBBS from NRI Medical College, NTRUHS
  • MD (General Medicine) from NIMS, Hyderabad
  • DM (Rheumatology) from NIMS, Hyderabad
• Rheumatoid Arthritis, Osteoarthritis
• SLE (Lupus), Sjogren’s syndrome, Scleroderma, Mixed connective disorder
• Spondyloarthritis- Ankylosing Spondylitis, Psoriatic arthritis, IBD related arthritis
• Antiphospholipid syndrome (APS)
• Crystal arthropathy- Gout, CPPD
• Vasculitis- Takayasu arteritis, Wegners Granulomatosus(GPA), Polyarteritis nodosa(PAN)
• Pediatric Connective Tissue Disorders, Juvenile Arthritis
• Myositis (Dermatomyositis, Polymyositis)
• Lung dominant CTD (Interstitial Lung Diseases-ILD)
• Primary Immunodeficiency syndromes.
• Sarcoidosis
• Metabolic Bone diseases, Osteoporosis
Membership
• Indian Rheumatology Association (LM 1202)
• API (Association of Physicians of India)
• Indian Society for Primary Immune Deficiency ISPID (ISPID/18/S-21)
• MyoIN (Myositis India Research group)

Publications:

1. Appani S, Devarasetti P, Irlapati R, Rajasekhar L. Methotrexate achieves major cDAPSA response,
and improvement in dactylitis and functional status in psoriatic arthritis. Rheumatology. 2018.
(doi.org/10.1093/rheumatology/key369)
2. Diffuse Alveolar Hemorrhage in Systemic Lupus Erythematosus - A Single Center Experience from
INDIA Journal: Rheumatology Advances in Practice Manuscript ID RHEUMAP-2018-009 (in
communication)